RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > As Final Guidance is Released, Deadline for PET Drug Compliance Draws Near

As Final Guidance is Released, Deadline for PET Drug Compliance Draws Near

Posted 12 April 2012 | By Alexander Gaffney, RAC 

Manufacturers of positron emission tomography (PET) drugs have until 12 June 2012 to comply with new regulations posted by the US Food and Drug Administration (FDA) on 10 April, reports In-Pharma Technologist.

As Regulatory Focus previously reported, FDA has released draft guidance for FDA Oversight of PET Drug Products- Questions and Answers on 27 February, and released final guidance under the same name on 10 April.

While the comment period for that final guidance document ends 29 May, compliance with the guidance must occur by 12 June. 

Manufacturers unable to comply with the current good manufacturing practices regulations at that time will be forced to find a new supplier, writes In-Pharma Technologist, which raises the possibility of exacerbating existing drug shortage problems.

The guideline, which covers aseptic manufacturing practices for media fills, should be useful for PET drug manufacturers who needed clarification on the process.

Read more:

In-Pharma Technologist - FDA posts media fill guidance to help PET drug manufacturers

Regulatory Focus - FDA Releases New Draft Guidance on PET Drug Products

Regulatory Focus - FDA Publishes New Guidance on PET Drug GMPs


© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.